mvt-1075
Generic: HuMab-5B1 radioimmunotherapy·Code: HuMab-5B1
mvt-1075: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) | Phase 1 |
Get deeper analysis on mvt-1075
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis